EUVIMEDEUVIMED entdecken
Multizentrische StudieLeitlinieQualitative StudieOpen Access · CC BY 4.0

Barriers and Enablers to Guideline-Directed Prescribing for Heart Failure with Reduced Ejection Fraction: A Multi-Stakeholder Qualitative Study

Barrieren und Förderfaktoren für leitliniengerechtes Verordnen bei Herzinsuffizienz mit reduzierter Ejektionsfraktion: eine multistakeholder qualitative Studie

Thin Mar Win iD, Audry Shan Yin Lee iD, Sameera Senanayake iD, Nicholas Graves iD, Sanjeewa Kularatna iD, Raymond Ching Chiew Wong iD, Seet Yoong Loh, Tan Yuyang, Huang Weiliang iD, Chow Weien iD, Jeanne Shan Yin Ong, Peck Kah Hua und 5 weitere

Global Heart · 30.10.2026 · 21 (1) · 79

DOI: 10.5334/gh.1596 ↗

Auf einen Blick

38 Gesundheitsfachpersonen aus 7 öffentlichen Einrichtungen in Singapur berichteten Barrieren und Förderfaktoren für die Verordnung und Titration der Quadruple Therapy bei Herzinsuffizienz mit reduzierter Ejektionsfraktion.

Fragestellung

Welche Barrieren und Förderfaktoren beeinflussen Verordnung und Titration leitliniengerechter Therapie bei Herzinsuffizienz mit reduzierter Ejektionsfraktion in Singapur?

Methode

Halbstrukturierte Interviews mit 38 Gesundheitsfachpersonen aus 7 öffentlichen Einrichtungen in Singapur; Analyse nach Cabana-Rahmenwerk mit induktiv-deduktivem Vorgehen.

Ergebnisse

Leitlinienkenntnis war hoch, die Sicherheit beim Initiieren und Aufdosieren aber unterschiedlich. Genannt wurden u. a. Sicherheitsbedenken, klinische Trägheit, Rollengrenzen, finanzielle Hürden, geringe Gesundheitskompetenz und fragmentierte Akten.

Schlussfolgerung der Autor:innen

Zur Schließung der Lücke zwischen Leitlinie und Praxis werden zielgerichtete Toolkits und spezialistischer Support benötigt; außerdem sollen Verordnung, Adhärenz und Informationsintegration besser unterstützt werden.

Kernaussagen

  • Leitlinienwissen war hoch, die Sicherheit beim Aufdosieren variierte.
  • Nurse- oder pharmacist-geführte Titrationskliniken mit Support galten als Enabler.
  • Finanzielle, organisatorische und patientenbezogene Barrieren behinderten die Umsetzung.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Global Heart, online erschienen am 30.10.2026. Verfasst von Thin Mar Win und 16 weiteren Autor:innen. Beteiligte Einrichtung: Health Services Research and Population Health, Duke-NUS Medical School, 8 College Road, Singapore. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Guideline Adherence, Practice Guidelines as Topic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure with reduced ejection fraction remains a major cause of morbidity and mortality despite effective treatments. Guideline-directed medical therapy, commonly referred to as quadruple therapy, reduces mortality and hospitalisation; however, uptake and dose optimisation remain suboptimal across Asia, including Singapore. This study explores barriers and enablers influencing prescribing and titration practices in a multi-ethnic Asian setting.

Methods

We conducted semi-structured interviews with 38 healthcare providers from seven public healthcare institutions in Singapore, including cardiologists, clinicians from relevant subspecialties, nurses, and pharmacists. The study was informed by the Cabana framework, and data were analysed using an inductive-deductive approach.

Results

Guideline awareness was generally high, but confidence in initiating and up-titrating therapy varied. Attitudinal barriers included perceived gaps between clinical trial evidence and the realities of managing diverse patient populations, safety concerns in multi-morbid patients, clinical inertia, challenges related to professional boundaries, and limited confidence among junior staff. Nonetheless, guidelines were perceived as enablers, providing a shared framework that promotes standardised care. Prescribing behaviour was shaped by patient-related factors including financial constraints, limited health literacy, cultural preferences for traditional medicines, and treatment outcomes. Organisational barriers included limited access to specialist follow-up, rotating inpatient teams, formulary gaps in primary care, and fragmented medical records. Multidisciplinary nurse- or pharmacist-led titration clinics with specialist support were a key institutional enabler.

Conclusions

To narrow the guideline-practice gap, targeted toolkits and specialist support are needed to address concerns and build staff confidence. A culture of reviewing quadruple therapy prescription at discharge and during follow-up should be supported. Prescribing patterns should be monitored and reflected in real-time, and patient adherence strengthened through dedicated heart failure nurses or case managers. Telehealth or primary care-based services, increased government support for healthcare information integration, and increased financial support for patients are necessary. Lay Summary Heart failure with reduced ejection fraction is a serious medical condition that can lead to frequent hospital admissions and premature death. Clinical guidelines strongly recommend the use of four classes of evidence-based medicines, commonly known as quadruple therapy, because they can significantly improve survival and reduce hospitalisation. Despite guideline endorsement, real-world uptake and dose optimisation of quadruple therapy remains suboptimal globally. Studies on implementation barriers in adhering to the guideline recommendations for quadruple therapy have focused mainly on physicians. This study provides one of the first multi-institutional qualitative accounts of barriers and enablers in prescribing quadruple therapy or guideline-directed medical therapy (GDMT) for heart failure patients in Singapore, exploring the views of all three frontline healthcare professional groups—doctors, nurses, and pharmacists. We found that the prescription of quadruple therapy was negatively influenced by a perceived gap between clinical trial evidence and the realities of managing diverse patient populations—particularly older and multimorbid patients—alongside interprofessional relationships and limited confidence among junior staff. Health care providers’ prescribing behaviour was shaped by patient-related factors, including financial constraints, limited health literacy, and cultural preferences for traditional medicines. Limited specialist follow-up, fragmented health records, and formulary gaps in primary care hinder implementation, while positive patient outcomes and multidisciplinary care models act as enablers in adhering to guideline recommendations. The study adds context-specific implementation insights by identifying individual, organisational, and system-level factors. Specialist-supported nurse- or pharmacist-led services, primary care-based medication titration, clearer task-sharing pathways, improved decision tools, and better health information integration may enhance guideline implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeGuideline AdherencePractice Guidelines as TopicPractice Patterns, Physicians'HumansSingaporeQualitative ResearchMaleFemale

Stichwörter der Autor:innen

Guideline-directed medical therapyHeart failure with reduced ejection fractionQuadruple therapySingapore

Autor:innen und Institutionen

  • Health Services Research and Population Health, Duke-NUS Medical School, 8 College Road, Singapore.
  • Department of Cardiology, National Heart Centre, 5 Hospital Drive, Singapore.
  • National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore.
  • Australian Centre for Health Services Innovation, School of Public Health and Social Work, QUT Centre for Healthcare Transformation, Faculty of Health, Queensland University of Technology, 88 Musk Avenue, Kelvin Grove,…
  • Yong Loo Lin School of Medicine, National University Singapore, 10 Medical Dr, Singapore.
  • Department of Cardiology, National University Heart Centre, 5 Lower Kent Ridge Rd, Singapore.

ORCID-Profile: Thin Mar Win, Audry Shan Yin Lee, Sameera Senanayake, Nicholas Graves, Sanjeewa Kularatna, Raymond Ching Chiew Wong, Huang Weiliang, Chow Weien, Derek J Hausenloy, Mark Yan-Yee Chan, Khung-Keong Yeo, Kheng Leng David Sim, Sungwon Yoon

Zitieren

APA

Win, T. M., Shan Yin Lee, A., Senanayake, S., Graves, N., Kularatna, S., Wong, R. C. C., Loh, S. Y., Yuyang, T., Weiliang, H., Weien, C., Ong, J. S. Y., Kah Hua, P., Hausenloy, D. J., Chan, M. Y., Yeo, K. K., Sim, K. L. D., & Yoon, S. (2026). Barriers and Enablers to Guideline-Directed Prescribing for Heart Failure with Reduced Ejection Fraction: A Multi-Stakeholder Qualitative Study. Global Heart, 21(1), 79. https://doi.org/10.5334/gh.1596

Vancouver

Win TM, Shan Yin Lee A, Senanayake S, Graves N, Kularatna S, Wong RCC, et al. Barriers and Enablers to Guideline-Directed Prescribing for Heart Failure with Reduced Ejection Fraction: A Multi-Stakeholder Qualitative Study. Global Heart. 2026;21(1):79. doi:10.5334/gh.1596

BibTeX
@article{Win2026,
  author = {Win, Thin Mar and Shan Yin Lee, Audry and Senanayake, Sameera and Graves, Nicholas and Kularatna, Sanjeewa and Wong, Raymond Ching Chiew and Loh, Seet Yoong and Yuyang, Tan and Weiliang, Huang and Weien, Chow and Ong, Jeanne Shan Yin and Kah Hua, Peck and Hausenloy, Derek J and Chan, Mark Yan-Yee and Yeo, Khung-Keong and Sim, Kheng Leng David and Yoon, Sungwon},
  title = {Barriers and Enablers to Guideline-Directed Prescribing for Heart Failure with Reduced Ejection Fraction: A Multi-Stakeholder Qualitative Study},
  journal = {Global Heart},
  year = {2026},
  volume = {21},
  number = {1},
  pages = {79},
  doi = {10.5334/gh.1596}
}
Kostenlos starten →